论文部分内容阅读
Aim: To find an appropriate dose regimen of antofloxacin, a concentration dependent antibacterial agent,for phase Ⅱ clinical trial through a population pharmacokinetic (PPK) study in healthy volunteers and the minimum inhibitory concentration (MIC) as pharmacodynamic (PD) parameters.